GIP
WST icon

Granite Investment Partners’s West Pharmaceutical WST Stock Holding History

Granite Investment Partners’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-22,340
Closed -$3.4M – 299
2020
Q1 		$3.4M Sell
22,340
-3,548
-14% -$546K 0.22% 115
2019
Q4 		$3.89M Buy
25,888
+9,412
+57% +$1.37M 0.18% 125
2019
Q3 		$2.34M Buy
16,476
+460
+3% +$63.3K 0.12% 146
2019
Q2 		$2M Buy
16,016
+7,204
+82% +$850K 0.11% 146
2019
Q1 		$971K Buy
+8,812
New +$917K 0.06% 231

Other funds holding WST

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
DCP
Durable Capital Partners Bethesda, Maryland $10.3B AUM 29.04% 1-Year Est. Return

Granite Investment Partners's WST Position: Q2 2020 in Review

Granite Investment Partners sold out of West Pharmaceutical (WST) in Q2 2020, closing a stake of 22,340 shares — an estimated $3.4M sold.

Granite Investment Partners first reported a position in WST in Q1 2019 and held it in 5 quarters. The position peaked at $3.89M in Q4 2019. 524 funds tracked by Wall St. Rank hold WST as of Q2 2020.

  • Granite Investment Partners reported no remaining West Pharmaceutical position as of Q2 2020 after selling out during the quarter.
  • Granite Investment Partners sold 22,340 West Pharmaceutical shares in Q2 2020, an estimated $3.4M.
  • Granite Investment Partners first reported a position in West Pharmaceutical in Q1 2019 and held it in 5 quarters.
  • Granite Investment Partners's West Pharmaceutical position peaked at $3.89M in Q4 2019.
  • 524 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2020.

Based on Granite Investment Partners's 13F filing for Q2 2020, filed 3 Aug 2020.